Fig. 4

Normalized changes in muscle soreness (A), PPT (B), muscle function (C), IL-6 (D), TNF- alpha (E), CK (F), LDH (G), from the baseline, at before EIMD protocol (pre), Immediately after EIMD protocol (0 h), 24 h, 48 h, and 72 h for the NM and placebo NM groups. * Significant differences with respect to Baseline. ** Indicates a significant interaction effect